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General objective: To evaluate the understanding and perceptions of generic medicines among 
final-year Doctor of Pharmacy students in Karachi, Pakistan.
Methods: A 23-item survey instrument that included a question on the bioequivalence limits and 
Likert-type scale questions regarding the understanding and perceptions of generic medicines 
among the students was executed. Cronbach’s alpha was found to be 0.62.
Results: Responses were obtained from 236 final-year Doctor of Pharmacy students (n=85 
from a publicly funded institute; n=151 from a privately funded institute). When comparing a 
brand-name medicine to a generic medicine, pharmacy students scored poorly on bioequivalence 
limits. More than 80% of the students incorrectly answered that all the products that are rated as 
generic equivalents are therapeutically equivalent to each other (P,0.04). Half of the students 
agreed that a generic medicine is bioequivalent to the brand-name medicine (P,0.001). With 
regard to quality, effectiveness, and safety, more than 75% of the students disagreed that generic 
medicines are of inferior quality and are less effective than brand-name medicines (P,0.001). 
More than 50% of the students disagreed that generic medicines produce more side effects than 
brand-name medicines (P,0.001).
Conclusion: The current study identified a positive perception toward generic medicines but 
also gaps in the understanding of generic medicines. Pharmacy students lacked a thorough 
understanding of the concepts of bioequivalence. Pharmacy academia should address these 
issues, which will help build confidence in generic medicines and increase the generic medicine 
use in Pakistan.
Keywords: safety, curriculum, efficacy
Introduction
Aging population and expensive medicines are the hallmarks of any health care system 
globally.1 The use of generic medicines is considered a cost-effective measure to curtail 
health care expenditures on pharmaceuticals, rendering substantial savings to the popu-
lation and the government alike.1,2 The backbone of any health care system mainly com-
prises of physicians, pharmacists, nurses, and dentists.3,4 In order to strengthen the health 
care system, the role of the pharmacist is evolved from a dispenser to patient-centered 
caregiver, counselor, and decision-maker.5 Whether in the developed or developing 
nations, pharmacists are generally the direct and first line of contact with the patients 
and therefore signify as health-information professionals expected to give advice 
regarding dosage regimen, side effects, adverse effects, and drug–drug interactions and 
to participate in the multidisciplinary team as a practicing  pharmacist.5–7 Studies from 
both the developed and developing countries have  highlighted  pharmacists’ attitudes, 
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perceptions, and willingness to counsel on health-related 
issues and pharmaceutical care, as well as their involvement 
in hospital rotations, to improve patient care and decrease 
drug costs to patients.8–11 Pharmacists are also involved in 
suggesting brand substitutes to patients and promoting cost-
effective generic alternatives, and their knowledge, percep-
tions, attitudes, and practices regarding generic medicine 
use and generic substitution were reported previously in the 
literature.12–21
The health delivery system of Pakistan offers health 
care services for 22% of the country’s population and, con-
sequently, 78% of the population resort to out-of-pocket 
payment for their access to health care services.22 With more 
than half of the population living below the poverty line, 
medicine prices hike from 20% to 80% and thus pose an 
additional burden on the millions of Pakistani patients.23 This 
clearly highlights the need for cost-effective generic alterna-
tives. Interestingly, the pharmaceutical market in Pakistan is 
dominated by locally manufactured pharmaceuticals, chiefly 
generic drugs, which covered around 90% of the country’s 
needs in 2011.24 Multinational companies justifies for around 
half of the market by value, although local producers have a 
major share in terms of volume.22 The Government of Paki-
stan promotes the sale of effective and quality generic drugs at 
affordable prices to patients. Moreover, after the proclamation 
of the Drug Regulatory Authority of Pakistan (DRAP) Act, 
the registration process has been revisited and refurbished 
and thus strengthened to ensure safety efficacy and qual-
ity of drugs, and therefore the manufacturing of generic 
drugs is being strengthened and expedited.25 Pharmacists 
are generally the first point of contact with the consumers 
and/or patients, and this places them in an improved situa-
tion to advise health care professionals as well as consumers 
about generic medicines. Previous studies have highlighted 
that transforming prescribing and/or dispensing behavior is 
an ardent task.26,27 Therefore, the pharmacists, right from the 
stage of their academic and professional training, need to be 
well equipped to suggest less expensive generic alternatives. 
To be precise, pharmacy students are future practitioners and 
their knowledge and attitudes can play an important role in 
promoting quality use of medicines.28
literature review
Student pharmacists can exercise reflective influence on 
patient care and can practice as knowledgeable and competent 
pharmacists, provided they are exposed to extensive clini-
cal clerkships and hospital rotations during their academic 
period. Many previously published research studies took into 
account the role of the student pharmacist in adjusting the 
dose of the medicines and highlighting drug–drug interac-
tions, drug–food interactions, side effects, and/or adverse 
effects,14,28,29 but only a few studies have highlighted the role 
of the student pharmacist in cost-saving recommendations 
and generic substitutions.29–31 Likewise, only a few studies 
have explored the knowledge and perceptions of student 
pharmacists about generic medicines.32–35 Therefore, it is 
imperative to explore the understanding and perceptions of 
student pharmacists about generic medicine use and generic 
substitution.
Justification of the current research
The pharmaceutical sector of Pakistan is objectively delin-
eated between domestically produced generic drugs and 
imported branded prescription pharmaceuticals,22 and the 
local pharmaceutical industry captures about 70%–85% 
of the total market.22 With the patent expiry of some major 
innovators, the generics-dominated local pharmaceutical 
industry is expected to benefit more and, therefore, this cur-
rent research is important.
There is no requirement that generic drugs submit effec-
tive bioequivalence data and this raises a question about the 
efficacy and safety of generics.22
To be precise, underutilization of generic medicines and 
the factors affecting underutilization of generic medicines 
are less explored areas in the context of Pakistan. With the 
local pharmaceutical industry holding a large market share 
(by volume) coupled with the market of Pakistan being 
flooded with branded generics, research into the factors 
affecting the contemporary issues of underutilization of 
generics is vital.
Objectives
The objectives of the current research were to explore the 
understanding and perceptions of pharmacy students about 
generic medicines and also to document the association of 
understanding and perception with sex, age, and institution. 
The current research also aimed to explore the views of stu-
dents about the learning of bioequivalence concepts.
Methodology
There is a paucity of research evidence from developing 
countries regarding the understanding and perceptions of 
future pharmacy practitioners about generic medicines. In 
order to explore the research objectives both in depth and 
in breadth, mixed methods research is the most suitable 
option in the current study, as it employs both qualitative 
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and  quantitative methods.36 This current study also used a 
combination of data collection methods and data analysis 
in sequential phases. Therefore, in the light of the method-
ological design, the study was conducted in two phases, ie, 
a qualitative (first) and quantitative (second) phase. The first 
part of the study was presented and published in 2010.37 The 
qualitative part, in which 28 semi-structured  face-to-face 
interviews were conducted, addressed the understanding 
and perceptions of final-year pharmacy students. Student 
pharmacists reported misunderstanding about the concept 
of generic medicines and expressed lack of understanding 
of bioequivalent concepts of generics.37
Quantitative methods
As mentioned, the current study used a mixed methods 
approach, and thus quantitative instrument design, quan-
titative data collection, and quantitative data analysis were 
followed subsequently after the completion of the qualitative 
phase (first phase).
Study setting and sample
This study was performed among pharmacy students at two 
pharmacy institutes in Karachi, Pakistan from January 2009 
to February 2009. The researcher identified six pharmacy 
institutes in Karachi, Pakistan who had final-year students. 
On the basis of “pioneers in pharmacy education”, one 
government-sponsored and one privately funded pharmacy 
institute were purposively selected for this study. Final-year 
Doctor of Pharmacy (Pharm D) students from a government-
sponsored (n=85) and a privately funded (n=151) institute 
were invited to participate in the study during their lecture 
session. In this study, the students were recruited and 
informed through an official notification from the dean. 
The office order stated the objectives of the study and were 
displayed on the notice board of the Faculty of Pharmacy. 
Participation was voluntary; however, all final-year Pharm 
D students participated in the study. As no personal iden-
tification was required, the students were not asked to fill 
out a consent form. The questionnaire was administered in 
the last week of the final semester, after which the students 
would have to appear for the final examination.
Survey instrument
As the main purpose of the qualitative phase was to estab-
lish a background for the development of a quantitative 
survey instrument, the questionnaire used by Hassali et al 
was modified in the light of qualitative analysis.34 The 
modified 23-item questionnaire was subjected to face 
validity and content validity by sending it to pharmacy 
academics who gave feedback on the appropriateness of 
items. The questionnaire was then subjected to pilot test-
ing, and Cronbach’s alpha was computed. The 23-item 
questionnaire consists of three sections, ie, demographic 
information of the students (three items); understanding 
and perceptions of the students regarding the bioequiva-
lence, safety, and efficacy profile of generic medicines in 
comparison to brand medicines as well as generic substitu-
tion (14 items); and views of the students about the learn-
ing of bioequivalence with respect to safety and efficacy 
of generic medicines (five items). The 19 items used a 
5-point Likert scale (5= strongly agree to 1= strongly 
disagree), with only one item pertinent to the issue of 
bioequivalence regulatory limits. At the beginning of the 
questionnaire there was one statement about the definition 
of bioavailability, which was read out to the students by the 
researcher. The item related to the issue of bioequivalence 
regulatory limits read as follows:
The regulatory limits applied are that 90% confidence 
intervals for the ratios (generic product: brand name prod-
uct) of areas under plasma drug concentration versus time 
curves and maximum plasma drug concentration must fall 
between […].
For this statement, six options were given to the 
 respondents. The correct option was 80%–125%.
Data analysis
The data were entered into SPSS version 17.0 software. 
Descriptive statistics were applied to summarize the data. 
In order to explore the normality assumptions, descriptive 
statistics were performed to get skewness and kurtosis. 
Data were found to be not normally distributed, and cross-
tabulation was done to examine the relationship between the 
variables. In order to test the association between categorical 
variables, chi square was applied. In case chi square failed 
to fit its assumption, then Fisher’s exact test was applied. 
A P-value of less than 0.05 was considered significant.
Results
The Cronbach’s alpha was found to be 0.62. The total num-
ber of final-year Pharm D students who participated in the 
study was 236. Demographics of the pharmacy students are 
shown in Table 1.
The first survey statement was related to the regulatory 
limits applied for bioequivalence in comparison to originator 
with generic alternatives. For the ease of tabulation, three 
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Table 1 Demographics of the pharmacy students
Item Frequency Percent
Age group
 20–23 years 194 82.2
 24–26 years 42 17.8
sex
 Male 65 27.5
 Female 171 72.5
institution
 Public 85 36
 Private 151 64
Table 2 Understanding of and perceptions toward generic medicines
Statements/items Strongly 
agree 
n (%)
Agree 
n (%)
Neutral 
n (%)
Disagree 
n (%)
Strongly 
disagree  
n (%)
Sex 
P-value
Universitya 
P-value
All generic products of a particular medicine that  
are rated as generic equivalents are therapeutically  
equivalent to the innovator brand product
59 (25.0) 121 (51.3) 15 (6.4) 36 (15.3) 5 (2.1) 0.168 0.513
All generic products of a particular medicine that  
are rated as generic equivalents are therapeutically  
equivalent to each other
71 (30.1) 127 (53.8) 11 (4.7) 26 (11.0) 1 (0.4) 0.104 0.028*
A generic medicine is bioequivalent  
to a brand name medicine
27 (11.4) 91 (38.6) 36 (15.3) 70 (29.7) 12 (5.1) 0.001* 0.595
A generic medicine must be in the same dosage form  
(eg, tablet, capsule) as the brand name medicine
26 (11.0) 65 (27.5) 27 (11.4) 96 (40.7) 22 (9.3) 0.366 0.001*
A generic medicine must contain the same dose  
as the brand name medicine
39 (16.5) 98 (41.5) 16 (6.8) 76 (32.2) 7 (3.0) 0.047* 0.573
Generic medicines are of inferior quality  
to branded drugs
4 (1.7) 31 (13.1) 22 (9.3) 127 (53.8) 52 (22.0) 0.485 0.001*
generic medicines are less effective than  
brand name medicines
6 (2.5) 21 (8.9) 21 (8.9) 139 (58.9) 49 (20.8) 0.115 0.001*
Generic medicines produce more side-effects  
than brand name medicines
4 (1.7) 40 (16.9) 45 (19.1) 109 (46.2) 38 (16.1) 0.164 0.001*
generic medicines are less expensive than  
brand name medicines
28 (11.9) 91 (38.6) 40 (16.9) 65 (27.5) 12 (5.1) 0.101  0.149
Brand name medicines are required to meet  
higher safety standards than generic medicines
19 (8.1) 104 (44.1) 33 (14.0) 60 (25.4) 20 (8.5) 0.006* 0.001*
From the knowledge I have, I’m confident  
in dispensing in future by generic drug name  
rather than brand name
70 (29.7) 110 (42.4) 34 (14.4) 28 (11.9) 4 (1.7) 0.047* 0.334
I find it easier to recall a medicine’s therapeutic  
class using generic names rather than brand names
116 (49.2) 99 (41.9) 7 (30.7) 11 (4.7) 3 (1.3) 0.230 0.191
I believe that pharmacists are one of the most  
important health care professionals to give advice  
on generic medicines
171 (72.5) 62 (26.3) 1 (4.0) 1 (4.0) 1 (4.0) 0.002* 0.508
I believe that multinational products are of good  
quality than local company products
121 (51.3) 93 (39.4) 11 (4.7) 11 (4.7) 0 0.671 0.510
Notes: aPublic or private university. *P,0.05.
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categories, “correct”, “incorrect”, and “do not know”, were 
assigned. Out of 236 respondents, only 12 (5.1%) students 
answered correctly, while the rest answered either incorrectly 
(72%; n=170) or did not know anything about bioequivalence 
limits (22.9%; n=54).
Tables 2 and 3 show the responses of final-year Pharm D 
students regarding their understanding and perceptions of 
generic medicines as well as students’ views about the learn-
ing of bioequivalence with respect to safety and efficacy of 
generic medicines.
Understanding of generic medicines
A medicine that is considered a “generic equivalent” will 
demonstrate therapeutic equivalence to brand-name products, 
but not all generic equivalents will demonstrate therapeutic 
equivalence to each other. When questions about this were 
asked of the respondents, more than 80% of the students 
incorrectly “strongly agreed” (30.1%; n=71) and “agreed” 
(53.8%; n=127) that all generic products of a particular medi-
cine that are rated as generic equivalents are therapeutically 
equivalent to each other. This response showed statistical 
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Table 3 Students’ views on bioequivalence
Statements/items Strongly  
agree 
n (%)
Agree 
n (%)
Neutral 
n (%)
Disagree 
n (%)
Strongly 
disagree 
n (%)
Sex 
P-value
Universitya 
P-value
I have not been introduced to the issues of bioequivalence  
for generic medicines during my pharmacy education
14 (5.9) 44 (18.6) 16 (6.8) 104 (44.1) 58 (24.6) 0.012 0.002*
I need more information on how bioequivalence tests  
are conducted for generic medicines
95 (40.3) 128 (54.2) 11 (4.7) 2 (0.8) 0 0.536 0.001*
i need more information on the issues pertaining  
to the efficacy and safety of generic medicines
69 (29.2) 152 (64.4) 9 (3.8) 5 (2.1) 1 (0.4) 0.056 0.099
I believe that pharmacy curriculum should focus  
on cost-effective dispensing
64 (27.1) 149 (63.1) 11 (4.7) 12 (5.1) 0 0.396 0.001*
I believe that pharmacy curriculum should involve aspects  
on National Drug Policy and National Essential Drug List
66 (28.0) 142 (60.2) 23 (9.7) 5 (2.1) 0 0.655 0.228
Notes: aPublic or private university. *P,0.05.
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significance with respect to university (P,0.046), and higher 
association was observed in private university students.
Half of the students (50%; n=118) “strongly agreed” 
and “agreed” that a generic medicine is bioequivalent to 
the brand-name medicine. In terms of dosage form, nearly 
40% (38.5%; n=91) of the students agreed that generic 
medicine must be available in the same dosage form as 
brand-name medicine. These responses showed statistical 
significance with respect to sex and university (P,0.001), 
and greater association was noted among the males of the 
public university.
Understanding of the safety  
standards of generic medicines
Interestingly, the understanding about the requirements of 
safety standards of brands and generic medicines seemed to 
be divided. Just over half of the pharmacy students (52.2%; 
n=123) wrongly believed that brand-name medicines are 
required to meet higher safety standards than generic 
medicines. The response showed statistical significance with 
respect to university (P,0.001).
Perceptions toward generic medicines
In terms of quality, effectiveness, and safety, more than 75% 
of the students either “disagreed” or “strongly disagreed” 
that generic medicines are of inferior quality (75.8%; n=179) 
and are less effective than brand-name medicines (79.7%; 
n=188). More than half of the students “disagreed” (62.3%; 
n=147) that generic medicines produce more side effects than 
brand-name medicines. These responses showed statistical 
significance with respect to university (P,0.001), with bet-
ter perceptions observed in public university students. More 
than 70% of the students (72.1%; n=180) expressed their 
confidence in dispensing by generic name rather than brand 
name. This showed a statistical significance with respect to 
sex (P,0.04), with greater association seen in female student 
pharmacists.
Views on bioequivalence
With regard to students’ views about bioequivalence, a large 
number of students (68.7%; n=162) “strongly disagreed” 
and “disagreed” that they are not introduced to the issues 
of bioequivalence for generic medicines during pharmacy 
education, but more than 90% (94.5%; n=223) expressed 
their curiosity to know more about bioequivalence tests for 
generic medicines. Both of these responses were found to be 
statistically significant with respect to university (P,0.002; 
P,0.001), with better views reflected by public university 
students. Although not statistically significant, it is worth 
mentioning that the majority of the pharmacy students 
believed that the pharmacy curriculum should include aspects 
on the National Drug Policy and the National Essential Drug 
List (88.2%; n=208).
Discussion
In the present era of spiraling health care costs, there is a need 
for cost-effective generic alternatives. The Government of 
Pakistan endorsed this concept and thus educators of health 
care professionals are responsible for teaching and training 
future practitioners about the utilization of cost-effective 
medicines. In order to deal with the contemporary issues of 
underutilization of generic medicines, it is imperative that 
health care professionals demonstrate understanding of and 
sound perceptions toward generic alternatives. Thus, the cur-
rent research was carried out to explore the understanding and 
perceptions of pharmacy students about generic medicines.
Moreover, to the best of our knowledge, the current 
study is the first of its kind in evaluating final-year Pharm D 
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 students’ understanding and perceptions of generic  medicines 
in Pakistan. The current study showed gaps in the under-
standing of basic concepts of generic medicines in final-year 
Pharm D students. This is in accordance with the results of 
the qualitative study, in which student pharmacists showed 
gaps in understanding of the basic concepts of generic 
medicines and their bioequivalence criteria.37 Likewise, 
studies done in Australia, Iraq, and Bangladesh on future 
pharmacy and medical practitioners also reported knowl-
edge gaps and lack of understanding of issues related to 
the use of generic medicines.32–34 In the current research, a 
higher proportion of correct responses was measured from 
government-sponsored university students. This is most likely 
due to different teaching styles in each university, which is 
attributed to highly qualified and experienced teaching staff 
in government-sponsored universities. With regard to per-
ceptions toward generic medicines, the students seem to be 
positive. In the current research, a large majority of students 
disagreed that generic medicines are of inferior quality and 
are less effective than brand-name medicines. Nearly half of 
the students disagreed that generic medicines produce more 
side effects than brand-name medicines. Female students 
from the government-sponsored university showed higher 
confidence in dispensing by generic name rather than brand 
name. Moreover, in the current study, a higher proportion of 
students from the government-sponsored university showed 
eagerness to know about bioequivalence tests.
The findings of the current study do not correlate well 
with the previous studies done in Australia and Bangladesh, 
wherein pharmacy preregistrants and medical students con-
sidered generic medicines to be inferior, less effective, and 
having more side effects than brand-name medicines.32,34
The differences in findings between the current study 
and other international studies may be due to the generics-
 dominated local industry in Pakistan, resulting in the sensiti-
zation of the faculty towards generic medicines. Furthermore, 
lectures on generic medicines might have been conducted 
in the final semester. Moreover, orientation sessions from 
the local pharmaceutical industries in both pharmacy uni-
versities in the final semester may partly contribute to the 
differences in the understanding and perceptions of generic 
medicines when compared to previous studies.32,34
As highlighted by McGivney, training of future phar-
macy practitioners in practice sites contributes to better 
patient care.38 The implementation of a similar concept 
to hands-on training to future pharmacy practitioners in 
Pakistan may result in better quality of care for patients.38 
 Regarding bioequivalence issues, students admitted that they 
were  introduced well to the concepts, but a poor response 
to questions about bioequivalence limits indicates a lack of 
understanding of this concept. These findings reflect the com-
plexity of topics of pharmacokinetics and biopharmaceutics 
that are difficult for the students to understand. A special 
course emphasizing bioequivalence and bioequivalence 
testing of generic medicines and highlighting the patients’ 
needs regarding generic substitution and interchangeability 
of brands with generic formulations could be helpful for 
future pharmacy practitioners. Moreover, a blended learn-
ing approach to teaching pharmacokinetics principles as 
well as mutual reviewing and discussion among teachers 
and students of the pharmacokinetics studies previously 
reported in the literature should be emphasized in a pharmacy 
curriculum.39
The basic principles of economics are taught in second-
year Pharm D in both of the surveyed universities, but the 
application of basic concepts of supply and demand, drug 
pricing, and the merits and disadvantages of brand-name 
medicines and generic medicines are lacking. A study done 
in USA reported that, as compared to pharmacists, pharmacy 
students made more recommendations to curtail health care 
expenses.29 Thus, incorporating case studies in economics 
courses in a pharmacy curriculum will help future practitio-
ners to develop into counselors of cost-effective regimens. 
Moreover, pharmacy students need to have knowledge about 
the National Drug Policy and the National Essential Drug 
List that contain information on cost-effective medicines. 
A pharmacoeconomics course, which is included as a subject 
in many pharmacy curricula globally,40–42 is recommended to 
be included in the pharmacy curriculum in Pakistan.
Limitations of the study
Regarding the limitations in the current study, the student 
participants were from two pharmacy institutes only, and 
this restricts the extrapolation of findings to other Doctor of 
Pharmacy programs in Pakistan.
General conclusion  
and recommendation
In the current study, gaps in understanding of the basic 
concepts of generic medicine and their bioequivalence were 
documented. This should be tackled by pharmacy educators, 
as pharmacists are the core loop in the health care chain, 
and their knowledge of generic medicines can inform both 
the prescriber and the patient on cost-effective regimens. 
Interestingly, in relation to perceptions, pharmacy students 
showed positive perceptions toward generic medicines.
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Pharmacy students and generic medicine
With regard to pharmacy curriculum, future strategies 
should be directed toward 1-year preregistration training or 
residency in the field of interest such as at a hospital or in 
industry. Universities are recommended to sign a memoran-
dum of understanding with different hospitals and pharma-
ceutical industries to foster a hands-on learning experience 
in the final professional year.
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